Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Gareth R. Bicknell is active.

Publication


Featured researches published by Gareth R. Bicknell.


Transplant International | 2007

Differential expression of cytoprotective and apoptotic genes in an ischaemia‐reperfusion isolated organ perfusion model of the transplanted kidney

Helen L. Waller; Simon J. F. Harper; Sarah A. Hosgood; Atul Bagul; Mark D. Kay; Monika Kaushik; Bin Yang; Gareth R. Bicknell; Michael L. Nicholson

The optimal kidney preservation system and methods to ameliorate reperfusion injury are major factors in accomplishing successful graft function following transplantation. Ischaemia and reperfusion lead to cellular stress and the adaptive response may include the activation of genes involved in cellular protection and/or cell death by apoptosis. We investigated the expression of cytoprotective heme oxygenase‐1 (HO‐1), anti‐apoptotic Bcl‐2 and pro‐apoptotic Bax after 6u2003h isolated organ perfusion in porcine kidneys that had been given 10 and 40u2003min warm ischaemic time. The level of HO‐1 was shown to be significantly higher in the 10‐min warm ischaemic group compared with 40‐min group (0.90u2003±u20030.03 vs. 0.83u2003±u20030.03; Pu2003=u20030.002). The levels of HO‐1 showed a significant positive correlated with parameters of renal function, creatinine clearance, and renal blood flow and urine output (AUC; ru2003=u20030.8042, Pu2003=u20030.03; ru2003=u20030.6028, Pu2003=u20030.04; ru2003=u20030.6055, Pu2003=u20030.04), demonstrating a possible protective role of this gene in this model of renal transplantation.


The Journal of Pathology | 2000

Inactive matrix metalloproteinase 2 is a normal constituent of human glomerular basement membrane. An immuno‐electron microscopic study

Sawsan M Jalalah; Peter N. Furness; Gordon Barker; Mark Thomas; Leon L. Hall; Gareth R. Bicknell; Jacqui A. Shaw; J. Howard Pringle

Remodelling of the extracellular matrix requires tight control not only of matrix synthesis, but also of matrix degradation. Control of matrix degradation is achieved mainly through the matrix metalloproteinase (MMP) enzymes. In the glomerulus, MMP‐2 and MMP‐9 are believed to be particularly important, as they have activity against type IV collagen. This study has demonstrated by immuno‐electron microscopy that most of the immunoreactivity for MMP‐2 in the normal glomerulus is located within the glomerular basement membranes and mesangial matrix. mRNA for MMP‐2 is also detectable in normal glomeruli, but the other main gelatinase, MMP‐9, could not be localized by immuno‐electron microscopy. In the normal glomerulus, it seemed likely that MMP‐2 is present in an inactive form. To confirm this, in situ zymography was carried out using frozen sections of normal kidney. Baseline activity of normal kidney was relatively weak, but this was dramatically increased by chemical activation of metalloproteinases. The results imply that MMP‐2, in an inactive form, is a normal constituent of the extracellular matrix and glomerular basement membranes. Activation would presumably render the matrix ‘self‐degrading’; membrane‐bound MMPs (MT‐MMPs) seem particularly likely to be involved in leukocyte penetration of basement membranes in inflammation. Copyright


BioTechniques | 1998

Reproducibility in the Quantification of mRNA Levels by RT-PCR-ELISA and RT Competitive-PCR-ELISA

L.L. Hall; Gareth R. Bicknell; L. Primrose; J.H. Pringle; Jacqui A. Shaw; Peter N. Furness


Journal of Surgical Research | 2005

The Experimental Agent Pirfenidone Reduces Pro-Fibrotic Gene Expression in a Model of Tacrolimus-Induced Nephrotoxicity

Nicholas R. Brook; Julian R. Waller; Gareth R. Bicknell; Michael L. Nicholson


Transplant International | 2004

Differential effects of modern immunosuppressive agents on the development of intimal hyperplasia

Julian R. Waller; Nicholas R. Brook; Gareth R. Bicknell; Michael L. Nicholson


Transplantation Proceedings | 2005

Cyclosporine and rapamycin act in a synergistic and dose-dependent manner in a model of immunosuppressant-induced kidney damage.

Nicholas R. Brook; Julian R. Waller; Gareth R. Bicknell; M. L. Nicholson


British Journal of Surgery | 2002

Effects of the combination of rapamycin with tacrolimus or cyclosporin on experimental intimal hyperplasia.

Julian R. Waller; Gavin J. Murphy; Gareth R. Bicknell; D. Toomey; M. L. Nicholson


Transplantation Proceedings | 2005

The novel antifibrotic agent pirfenidone attenuates the profibrotic environment generated by calcineurin inhibitors in the rat salt-depletion model.

Nicholas R. Brook; Julian R. Waller; Gareth R. Bicknell; M. L. Nicholson


web science | 2001

Effects of pirfenidone on vascular smooth muscle cell proliferation and intimal hyperplasia following arterial balloon injury

J.R Waller; Gavin J. Murphy; Matthew S. Metcalfe; Gareth R. Bicknell; R.N Saunders; S.B. Margolin; M. L. Nicholson


British Journal of Surgery | 2009

Patey Prize 04

Julian R. Waller; Gavin J. Murphy; Gareth R. Bicknell; D. Toomey; S.B. Margolin; M. L. Nicholson

Collaboration


Dive into the Gareth R. Bicknell's collaboration.

Top Co-Authors

Avatar

Julian R. Waller

Leicester General Hospital

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Peter N. Furness

Leicester General Hospital

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Atul Bagul

University of Leicester

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge